FOEHR MATTHEW W Insider Trading Activity

Average Profitability
16.4%
Insider Buys Quantity
23
Insider Buys Sum
$6.89M
Insider Sells Quantity
19
Insider Sells Sum
$13.78M

Insider Activity of FOEHR MATTHEW W

According to the SEC Form 4 filings, FOEHR MATTHEW W, being in a position of

  1. President and CEO at OmniAb, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 84507 shares for $143,482,
    over all time since 2023-05-12, has bought 1360000 shares for $5.91M, and sold 192820 shares for $497,056.

Biography of FOEHR MATTHEW W

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $705,1775100

Comparison of Insiders on Amount of Buys and Sells

2026-04-07SaleOmniAb, Inc.
OABI
President and CEO
19,244
0.0167%
$1.49$28,674+67.88%
2026-02-18SaleOmniAb, Inc.
OABI
President and CEO
30,843
0.0287%
$1.71$52,742+34.5%
2026-02-17SaleOmniAb, Inc.
OABI
President and CEO
20,754
0.0192%
$1.70$35,282+34.21%
2026-01-02SaleViking Therapeutics, Inc.
VKTX
director
16,000
0.0141%
$35.11$561,694-8.57%
2025-12-08SaleOmniAb, Inc.
OABI
President and CEO
13,666
0.0125%
$1.96$26,785+3.02%
2025-04-07SaleOmniAb, Inc.
OABI
President and CEO
19,382
0.0153%
$2.00$38,764-16.75%
2025-02-19SaleOmniAb, Inc.
OABI
President and CEO
19,522
0.0162%
$3.67$71,646-50.95%
2025-02-18SaleOmniAb, Inc.
OABI
President and CEO
13,964
0.0111%
$3.68$51,388-50.82%
2025-01-21SaleOmniAb, Inc.
OABI
President and CEO
41,811
0.0346%
$3.24$135,468-42.55%
2024-12-09SaleOmniAb, Inc.
OABI
President and CEO
13,634
0.0113%
$4.13$56,308-54.19%
2024-05-24PurchaseOmniAb, Inc.
OABI
President and CEO
240,000
0.2109%
$4.42$1.06M-11.85%
2024-03-22PurchaseOmniAb, Inc.
OABI
President and CEO
225,000
0.1948%
$5.19$1.17M-20.27%
2023-12-12PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
200,000
0.1722%
$5.05$1.01M-10.57%
2023-11-10PurchaseOmniAb, Inc.
OABI
President and CEO
95,000
0.0821%
$4.27$405,517+7.9%
2023-08-14PurchaseOmniAb, Inc.
OABI
President and CEO
45,000
0.0391%
$5.48$246,600-8.72%
2023-06-09PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
115,000
0.1157%
$4.52$519,800+14.35%
2023-05-12PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
440,000
0.4311%
$3.40$1.5M+48%
2022-05-13PurchaseLigand Pharmaceuticals Incorporated
LGND
President and COO
2,500
0.0143%
$82.76$206,910+21.82%
2022-05-02PurchaseViking Therapeutics, Inc.
VKTX
90,000
0.1144%
$2.47$222,390+53.75%
2021-06-10PurchaseViking Therapeutics, Inc.
VKTX
director
40,000
0.052%
$5.69$227,600-11.57%
Total: 43
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.